Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7777480 | 0.92 | BLM (0.38) | BLMPMP22HSD17B10TSHRMAPK1 | |
| SCHEMBL4294793 | 0.92 | TSHR (0.44) | BLMPMP22HSD17B10TSHRMAPK1 | |
| SCHEMBL12646242 | 0.89 | BLM (0.48) | BLMPMP22HSD17B10TSHRMAPK1 | |
| SCHEMBL7198059 | 0.88 | GAA (0.41) | BLMPMP22HSD17B10TSHRMAPK1 | |
| SCHEMBL2593277 | 0.86 | TSHR (0.56) | BLMPMP22HSD17B10TSHRMAPK1 | |
| SCHEMBL9161412 | 0.86 | BLM (0.41) | BLMPMP22HSD17B10TSHRMAPK1 | |
| SCHEMBL522377 | 0.86 | TSHR (0.56) | BLMPMP22HSD17B10TSHRMAPK1 | |
| SCHEMBL7777477 | 0.86 | BLM (0.39) | BLMPMP22HSD17B10TSHRMAPK1 | |
| SCHEMBL11613860 | 0.86 | BLM (0.34) | BLMPMP22HSD17B10TSHRMAPK1 | |
| SCHEMBL11528074 | 0.86 | BLM (0.34) | BLMPMP22HSD17B10TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | BLM 2264/4885PMP22 3347/4885HSD17B10 1914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.